J
Jaume Bosch
Researcher at University of Barcelona
Publications - 150
Citations - 13301
Jaume Bosch is an academic researcher from University of Barcelona. The author has contributed to research in topics: Portal hypertension & Portal venous pressure. The author has an hindex of 61, co-authored 150 publications receiving 11924 citations. Previous affiliations of Jaume Bosch include University of Bern & University Hospital of Bern.
Papers
More filters
Journal ArticleDOI
Angiogenesis in liver disease
TL;DR: This review summarizes current knowledge on the molecular mechanisms of liver angiogenesis and on the consequences ofAngiogenesis in chronic liver disease and presents the different strategies that have been used in experimental models to counteract excessive angiogenic activity.
Journal ArticleDOI
Pathophysiology of portal hypertension.
TL;DR: An expanded plasma volume is observed in all forms of portal hypertension, due to renal sodium retention, which has been shown to precede the increase in cardiac output and can be prevented or reversed by sodium restriction and spironolactone.
Journal ArticleDOI
Improved Clinical Outcome Using Polytetrafluoroethylene-Coated Stents for TIPS: Results of a Randomized Study
Christophe Bureau,Juan Carlos García-Pagán,Philippe Otal,Gilles Pomier-Layrargues,Valérie Chabbert,Carlos Cortez,Pierre Perreault,Jean-Marie Péron,Juan G. Abraldes,Louis Bouchard,José Ignacio Bilbao,Jaume Bosch,Hervé Rousseau,Jean-Pierre Vinel +13 more
TL;DR: The use of polytetrafluoroethylene-covered prostheses improves transjugular intrahepatic portosystemic shunt patency and decreases the number of clinical relapses and reinterventions without increasing the risk of encephalopathy.
Journal ArticleDOI
Clinical events after transjugular intrahepatic portosystemic shunt: Correlation with hemodynamic findings
Marta Casado,Jaume Bosch,Juan Carlos García-Pagán,Conxita Bru,Rafael Bañares,Juan Carlos Bandi,Angels Escorsell,J. M. Rodriguez-Laiz,Rosa Gilabert,Faust Feu,Carlos Schorlemer,A. Echenagusia,Joan Rodés +12 more
TL;DR: Total protection from the risk of recurrent complications of portal hypertension after a TIPS procedure requires that the PPG be decreased and maintained < 12 mm Hg, however, reintervention will be required in most patients within 1 year and again the second year.
Journal ArticleDOI
Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation
TL;DR: In this article, the authors evaluated the diagnostic accuracy of noninvasive measurement of liver stiffness (by transient elastography) to assess the severity of hepatitis C recurrence after liver transplantation.